R. S. Eydelloth

691 total citations
18 papers, 566 citations indexed

About

R. S. Eydelloth is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, R. S. Eydelloth has authored 18 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in R. S. Eydelloth's work include Renin-Angiotensin System Studies (6 papers), Hormonal Regulation and Hypertension (3 papers) and Pregnancy and preeclampsia studies (2 papers). R. S. Eydelloth is often cited by papers focused on Renin-Angiotensin System Studies (6 papers), Hormonal Regulation and Hypertension (3 papers) and Pregnancy and preeclampsia studies (2 papers). R. S. Eydelloth collaborates with scholars based in United States and France. R. S. Eydelloth's co-authors include Steven Vonderfecht, John F. Sheridan, Scott Grossman, Peter F. Smith, R.J. Stubbs, J. S. Macdonald, Michael S. Schwartz, Laure Aurelian, John I. Germershausen and Stan Spence and has published in prestigious journals such as Analytical Biochemistry, Journal of Virology and European Heart Journal.

In The Last Decade

R. S. Eydelloth

18 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. S. Eydelloth United States	12	173	131	120	119	78	18	566
Natalia Muñoz‐Durango Chile	12	171 1.0×	111 0.8×	81 0.7×	94 0.8×	25 0.3×	15	760
Ana Acácia S. Pinheiro Brazil	21	333 1.9×	119 0.9×	113 0.9×	130 1.1×	62 0.8×	64	1.1k
Soyoung Shin South Korea	14	421 2.4×	273 2.1×	56 0.5×	117 1.0×	38 0.5×	45	859
Peter C. Kolbeck United States	15	114 0.7×	162 1.2×	116 1.0×	122 1.0×	26 0.3×	24	841
J. C. Forest Canada	13	136 0.8×	27 0.2×	52 0.4×	61 0.5×	192 2.5×	23	537
Qingming Dong China	14	228 1.3×	44 0.3×	74 0.6×	230 1.9×	15 0.2×	35	764
S. Venkatesan United Kingdom	11	207 1.2×	21 0.2×	173 1.4×	69 0.6×	25 0.3×	25	537
Károly Mészáros United States	19	298 1.7×	42 0.3×	110 0.9×	31 0.3×	25 0.3×	35	1.2k
Xiaosong Qin China	17	233 1.3×	56 0.4×	53 0.4×	115 1.0×	37 0.5×	77	897
J Shepherd United Kingdom	10	282 1.6×	40 0.3×	188 1.6×	78 0.7×	14 0.2×	12	643

Countries citing papers authored by R. S. Eydelloth

Since Specialization

Citations

This map shows the geographic impact of R. S. Eydelloth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. S. Eydelloth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. S. Eydelloth more than expected).

Fields of papers citing papers by R. S. Eydelloth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. S. Eydelloth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. S. Eydelloth. The network helps show where R. S. Eydelloth may publish in the future.

Co-authorship network of co-authors of R. S. Eydelloth

This figure shows the co-authorship network connecting the top 25 collaborators of R. S. Eydelloth. A scholar is included among the top collaborators of R. S. Eydelloth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. S. Eydelloth. R. S. Eydelloth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Beconi, Maria, Cornelis E. C. A. Hop, S H Chiu, et al.. (2003). Species and gender differences in the formation of an active metabolite of a substituted 2,4-thiazolidinedione insulin sensitizer. Xenobiotica. 33(7). 767–787. 3 indexed citations

Grossman, Scott, et al.. (1997). Hepatotoxicity of an HIV Protease Inhibitor in Dogs and Rats. Toxicology and Applied Pharmacology. 146(1). 40–52. 5 indexed citations

Spence, Stan, et al.. (1996). Toxicokinetic analysis of losartan during gestation and lactation in the rat. Teratology. 53(4). 245–252. 23 indexed citations

Wise, L. David, et al.. (1995). Development and Submission of a Nonclinical (Pharmacology/Toxicology) CANDA. Regulatory Toxicology and Pharmacology. 22(1). 46–53. 2 indexed citations

Spence, Stan, Mark A. Cukierski, Jeanne M. Manson, Richard T. Robertson, & R. S. Eydelloth. (1995). Evaluation of the reproductive and developmental toxicity of the AT₁‐selective angiotensin II receptor antagonist Losartan in rats. Teratology. 51(6). 383–397. 22 indexed citations

Kraynak, Andrew R., Richard D. Storer, R Jensen, et al.. (1995). Extent and Persistence of Streptozotocin-Induced DNA Damage and Cell Proliferation in Rat Kidney as Determined by in Vivo Alkaline Elution and BrdUrd Labeling Assays. Toxicology and Applied Pharmacology. 135(2). 279–286. 64 indexed citations

Spence, Stan, Henry L. Allen, Mark A. Cukierski, et al.. (1995). Defining the susceptible period of developmental toxicity for the AT₁‐selective angiotensin II receptor antagonist Losartan in rats. Teratology. 51(6). 367–382. 54 indexed citations

Owen, Robin, et al.. (1995). The Morphology of Juxtaglomerular Cell Hyperplasia and Hypertrophy in Normotensive Rats and Monkeys Given an Angiotensin II Receptor Antagonist. Toxicologic Pathology. 23(3). 606–619. 24 indexed citations

Owen, Robin, et al.. (1994). Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.. PubMed. 71(4). 543–51. 9 indexed citations

10.

Owen, Robin, et al.. (1994). The Morphology of Juxtaglomerular Cell Hyperplasia and Hypertrophy in Normotensive Rats and Monkeys Given an Angiotensin II Receptor Antagonist. Toxicologic Pathology. 22(6). 606–619. 8 indexed citations

11.

Ledwith, Brian J., et al.. (1993). Measurement of Plasma Angiotensin II: Purification by Cation-Exchange Chromatography. Analytical Biochemistry. 213(2). 349–355. 9 indexed citations

12.

Smith, Peter F., Paul C. Stromberg, R. S. Eydelloth, et al.. (1992). Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicology and Applied Pharmacology. 116(1). 71–77. 58 indexed citations

13.

Smith, Philip, R. S. Eydelloth, Scott Grossman, et al.. (1992). Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cydosposin A: evaluation in a rat model. European Heart Journal. 13(suppl B). 2–6. 18 indexed citations

14.

Smith, Peter F., R. S. Eydelloth, Scott Grossman, et al.. (1991). HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.. Journal of Pharmacology and Experimental Therapeutics. 257(3). 1225–1235. 129 indexed citations

15.

Eydelloth, R. S., et al.. (1984). Kinetics of viral replication and local and systemic immune responses in experimental rotavirus infection. Journal of Virology. 50(3). 947–950. 43 indexed citations

16.

Eydelloth, R. S. & M. Michael Swindle. (1983). Intraductal Mammary Carcinoma and Benign Ovarian Teratoma in a Rhesus Monkey. Journal of Medical Primatology. 12(2). 101–105. 13 indexed citations

17.

Sheridan, John F., R. S. Eydelloth, Steven Vonderfecht, & Laure Aurelian. (1983). Virus-Specific Immunity in Neonatal and Adult Mouse Rotavirus Infection. Infection and Immunity. 39(2). 917–927. 66 indexed citations

18.

Eydelloth, R. S., et al.. (1982). Hemorrhagic streptococcal pneumonia in newly procured research dogs. Journal of the American Veterinary Medical Association. 181(11). 1371–1374. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact